Search
Collaborative team advances a new approach for imaging a drug that’s been developed to stop cancer growth.
Breast cancer risk varies widely among women who are carriers of the BRCA1 and BRCA2 mutations, according to a new study published in the January 9, 2008, issue of the Journal of the American Medical Association (JAMA).
New MSK research examines how diabetes may speed the growth of multiple myeloma; analyzes the increasing number of patients who are benefiting from precision oncology; and highlights the unexpected role of the integrated stress response in response to genomic instability in mitochondrial DNA.
Memorial Sloan Kettering Cancer Center and Gerstner Sloan Kettering President Craig Thompson and his wife opened their home for a reception for prospective Gerstner Sloan Kettering students invited for admissions interviews.
Experience a remarkable portrait of Black history in America through the family story of Dr. Selwyn Vickers, the President and CEO of Memorial Sloan Kettering Cancer Center.
A multicenter study led by Memorial Sloan Kettering researchers has answered an important question about the safety of using carbon nanotubes in medicine.
Meet Cancer Engineering MD-PhD candidate Brandon Cuevas: “Being able to be a bridge between medicine and research is such a privilege, one that not many places can offer.”
Dr. Hedvig Hricak is leading an international commission calling for a global strategy on improving access to more effective cancer care.
During meiosis, small chromosomes risk being lost in the shuffle. Here’s how they hold their own.